| Daniel A. Camardo |
Currently, Daniel A. Camardo occupies the position of Chief Executive Officer, Secretary, Director & CAO at Athersys, Inc. Mr. Camardo is also on the board of CommunityHealth NFP.
In his past career he held the position of President-US & Executive Vice President at Horizon Therapeutics Plc, Senior Director-US Commercial Operations at Astellas Pharma US, Inc. and Vice President-Sales & Operations at Clarus Therapeutics, Inc.
Mr. Camardo received an undergraduate degree from the University of Rochester and an MBA from Kellogg School of Management. |
| Kasey Rosado |
Kasey Rosado occupies the position of Chief Financial Officer at Athersys, Inc. She is also Senior Managing Director at Ankura Consulting Group LLC.
In the past Ms. Rosado held the position of Managing Director at CDG Group LLC.
She received an undergraduate degree from Syracuse University. |
| Rakesh Ramachandran |
Rakesh Ramachandran occupies the position of Head-Information Technology & Communications at Athersys, Inc.
Mr. Ramachandran received an undergraduate degree from Cochin University of Science & Technology and a graduate degree from Case Western Reserve University. |
| Maia A. Hansen |
Maia A. Hansen is on the board of Carlisle Cos., Inc. and Chief Operating Officer of Athersys, Inc.
She previously held the position of Senior Partner at McKinsey & Co., Inc.
Ms. Hansen received an undergraduate degree, a graduate degree and an MBA from Massachusetts Institute of Technology. |
| Jane Wasman |
Jane Wasman is a businessperson who has been at the head of 5 different companies. Presently, Ms. Wasman is Chairman at Athersys, Inc. and Independent Chairman of SELLAS Life Sciences Group, Inc., Chairman at Sellas Life Sciences Group Ltd. (a subsidiary of SELLAS Life Sciences Group, Inc.). She is also on the board of Rigel Pharmaceuticals, Inc., Biotie Therapies Oy and New York Biotechnology Association, Inc.
In her past career she occupied the position of Secretary & President-International at Acorda Therapeutics, Inc. and President, Secretary & General Counsel at Acorda Therapeutics Ltd. (a subsidiary of Acorda Therapeutics, Inc.), Chairman at SELLAS Life Sciences Group, Inc., Staff Vice President & Associate General Counsel at Schering-Plough Corp. and Associate General Counsel-Veteran Affairs at United States Senate.
Ms. Wasman received an undergraduate degree from Princeton University and a graduate degree from Harvard Law School. |
| Neema Mayhugh |
Neema Mayhugh is on the board of Athersys, Inc.
In her past career she occupied the position of Principal at Pfizer Inc. and Principal at The General Hospital Corp.
She received a doctorate from Dartmouth College and an undergraduate degree from Boston University. |
| Joseph Nolan |
Currently, Joseph Nolan is President, Chief Executive Officer & Director at Jaguar Gene Therapy LLC. He is also on the board of Athersys, Inc. and Axovia Therapeutics, Inc.
He previously was President of Eversana Life Science Services LLC, Chief Commercial Officer of Marathon Pharmaceuticals LLC and General Manager at Novartis Gene Therapies, Inc.
Joseph Nolan received an MBA from the University of Notre Dame and an undergraduate degree from Tulane University (Louisiana). |
| Jack L. Wyszomierski |
Jack L. Wyszomierski is on the board of XOMA Corp. and 6 other companies. He previously was Chief Financial Officer & Executive Vice President at Schering-Plough Corp., Chief Financial Officer & Executive Vice President for VWR International LLC, Chief Financial Officer & Executive Vice President at VWR Funding, Inc. and Principal at Joy Manufacturing Co.
Mr. Wyszomierski received an undergraduate degree and a graduate degree from Carnegie Mellon University. |
